<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35287333</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2167-4841</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Current pediatrics reports</Title><ISOAbbreviation>Curr Pediatr Rep</ISOAbbreviation></Journal><ArticleTitle>Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS.</ArticleTitle><Pagination><StartPage>31</StartPage><EndPage>44</EndPage><MedlinePgn>31-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40124-022-00261-4</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="UNASSIGNED">To discuss emerging understandings of adolescent long COVID or post-COVID-19 conditions, including proposed clinical definitions, common symptoms, epidemiology, overlaps with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and orthostatic intolerance, and preliminary guidance on management.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="UNASSIGNED">The recent World Health Organization clinical case definition of post-COVID-19 condition requires a history of probable or confirmed SARS-CoV-2 infection, with symptoms starting within 3&#xa0;months of the onset of COVID-19. Symptoms must last for at least 2&#xa0;months and cannot be explained by an alternative diagnosis. Common symptoms of the post-COVID-19 condition include, but are not limited to, fatigue, shortness of breath, and cognitive dysfunction. These symptoms generally have an impact on everyday functioning. The incidence of prolonged symptoms following SARS-CoV-2 infection has proven challenging to define, but it is now clear that those with relatively mild initial infections, without severe initial respiratory disease or end-organ injury, can still develop chronic impairments, with symptoms that overlap with conditions like ME/CFS (profound fatigue, unrefreshing sleep, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance).</AbstractText><AbstractText Label="SUMMARY" NlmCategory="UNASSIGNED">We do not yet have a clear understanding of the mechanisms by which individuals develop post-COVID-19 conditions. There may be several distinct types of long COVID that require different treatments. At this point, there is no single pharmacologic agent to effectively treat all symptoms. Because some presentations of post-COVID-19 conditions mimic disorders such as ME/CFS, treatment guidelines for this and related conditions can be helpful for managing post-COVID-19 symptoms.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The online version contains supplementary material available at 10.1007/s40124-022-00261-4.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morrow</LastName><ForeName>Amanda K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Kennedy Krieger Institute, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.240023.7</Identifier><Identifier Source="ISNI">0000 0004 0427 667X</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malone</LastName><ForeName>Laura A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Kennedy Krieger Institute, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.240023.7</Identifier><Identifier Source="ISNI">0000 0004 0427 667X</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokorelis</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kennedy Krieger Institute, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.240023.7</Identifier><Identifier Source="ISNI">0000 0004 0427 667X</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petracek</LastName><ForeName>Lindsay S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Adolescent/Young Adult Medicine, Johns Hopkins University School of Medicine, 200 N Wolfe St, Room 2077, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eastin</LastName><ForeName>Ella F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Adolescent/Young Adult Medicine, Johns Hopkins University School of Medicine, 200 N Wolfe St, Room 2077, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobner</LastName><ForeName>Katie L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Welch Medical Library, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuendorff</LastName><ForeName>Luise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, University of Toronto, Toronto, Canada.</Affiliation><Identifier Source="GRID">grid.17063.33</Identifier><Identifier Source="ISNI">0000 0001 2157 2938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Adolescent/Young Adult Medicine, Johns Hopkins University School of Medicine, 200 N Wolfe St, Room 2077, Baltimore, MD USA.</Affiliation><Identifier Source="GRID">grid.21107.35</Identifier><Identifier Source="ISNI">0000 0001 2171 9311</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Curr Pediatr Rep</MedlineTA><NlmUniqueID>101600850</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescent</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">Orthostatic intolerance</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 condition</Keyword></KeywordList><CoiStatement>Conflict of InterestThe authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>5</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35287333</ArticleId><ArticleId IdType="pmc">PMC8906524</ArticleId><ArticleId IdType="doi">10.1007/s40124-022-00261-4</ArticleId><ArticleId IdType="pii">261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU): COVID-19 Dashboard. https://coronavirus.jhu.edu/map.html (2022). Accessed January 14, 2022.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention: Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). https://www.cdc.gov/mis/mis-c/hcp/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmis%2Fhcp%2Findex.html (2021). Accessed December 30, 2021.</Citation></Reference><Reference><Citation>Farooqi KM, Chan A, Weller RJ, Mi J, Jiang P, Abrahams E, et al. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics. 2021;148(2). 10.1542/peds.2021-051155.</Citation><ArticleIdList><ArticleId IdType="pubmed">34266903</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, du Pr&#xe9; P, Lillie J, Kanthimathinathan HK. One-year outcomes of critical care patients post&#x2013;COVID-19 multisystem inflammatory syndrome in children. JAMA Pediatr. 2021;175(12):1281&#x2013;1283. doi: 10.1001/jamapediatrics.2021.2993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2993</ArticleId><ArticleId IdType="pmc">PMC8406209</ArticleId><ArticleId IdType="pubmed">34459875</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Centers for Disease Control and Prevention: Post-COVID conditions: information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html (2021). Accessed December 30, 2021. (Helpful clinical guidance.)</Citation></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, Akbari A, Emami A, Lotfi M, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17(5):495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2021 doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, Ziv A, Bar-On O, Birk E, et al. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021;40(12):e509&#x2013;e511. doi: 10.1097/inf.0000000000003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;e23. doi: 10.1016/s2352-4642(21)00124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020:2020.12.24.20248802. 10.1101/2020.12.24.20248802. (Important early on-line survey of long COVID symptoms in adults.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Espuny Pujol F, Munblit D, McFarland S, Simpson F. Clinical characteristics, activity levels and mental health problems in children with long COVID: a survey of 510 Children. Preprints.org; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9). 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175(11):1095&#x2013;1096. doi: 10.1001/jamapediatrics.2021.2281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2281</ArticleId><ArticleId IdType="pubmed">34338711</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AK, Ng R, Vargas G, Jashar DT, Henning E, Stinson N, et al. Postacute/long COVID in pediatrics: development of a multidisciplinary rehabilitation clinic and preliminary case series. Am J Phys Med Rehabil. 2021;100(12):1140&#x2013;1147. doi: 10.1097/phm.0000000000001896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/phm.0000000000001896</ArticleId><ArticleId IdType="pmc">PMC8594395</ArticleId><ArticleId IdType="pubmed">34793374</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel CLH, Lap CR, Buddingh EP, van Houten MA, van der Sande L, Langereis EJ, et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56(8):2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteudi T, Luciani L, Fabre A, Minodier P, Boucekine M, Bosdure E, et al. Clinical characteristics of paediatric COVID-19 patients followed for up to 13 months. Acta Paediatr. 2021;110(12):3331&#x2013;3333. doi: 10.1111/apa.16071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16071</ArticleId><ArticleId IdType="pmc">PMC8444774</ArticleId><ArticleId IdType="pubmed">34403523</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708&#x2013;718. doi: 10.1016/s2352-4642(21)00198-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(21)00198-x</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, Smane L, Kivite-Urtane A, Pucuka Z, Racko I, Klavina L, et al. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Frontiers in Pediatrics. 2021;9(1177). 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pereira S, Shafran R, De Stavola B, Rojas N, McOwat K, et al. Long COVID - the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. ResearchSquare. 2021 doi: 10.21203/rs.3.rs-798316/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-798316/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482&#x2013;e487. doi: 10.1097/inf.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/inf.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Fontaine KR, Lauver M, Jasion SE, Marden CL, Moni M, et al. Neuromuscular strain increases symptom intensity in chronic fatigue syndrome. PLoS ONE. 2016;11(7):e0159386. doi: 10.1371/journal.pone.0159386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159386</ArticleId><ArticleId IdType="pmc">PMC4948885</ArticleId><ArticleId IdType="pubmed">27428358</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CMC, Rowe PC, Verheugt FWA, Visser FC. Numeric rating scales show prolonged post-exertional symptoms after orthostatic testing of adults with myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Medicine. 2021;7(1083). 10.3389/fmed.2020.602894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874746</ArticleId><ArticleId IdType="pubmed">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. 2021;47(1):177. doi: 10.1186/s13052-021-01127-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Leftin Dobkin SC. Respiratory findings in children post-COVID-19 infection. American Journal of Respiratory and Critical Care Medicine. 2021;203(9). 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A3404.</Citation></Reference><Reference><Citation>Knoke L, Schlegtendal A, Maier C, Eitner L, Luecke T, Brinkmann F. More complaints than findings - Long-term pulmonary function in children and adolescents after COVID-19. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor MC, Faith MG, Roy HP. Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents. medRxiv. 2021. 10.1101/2021.09.28.21264259.</Citation></Reference><Reference><Citation>Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood &amp; cognitive impairment. Brain Behav Immun Health. 2021;17:100347. doi: 10.1016/j.bbih.2021.100347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021;175(11):1142&#x2013;1150. doi: 10.1001/jamapediatrics.2021.2482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2482</ArticleId><ArticleId IdType="pmc">PMC8353576</ArticleId><ArticleId IdType="pubmed">34369987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children &#x2014; a nationwide cohort study. Eur J Pediatr. 2022 doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2022. (Rich database on persistent symptoms post-COVID by age and impact.)</Citation></Reference><Reference><Citation>&#x2022; Carf&#xec; A, Bernabei R, Landi F, Group ftGAC-P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. 10.1001/jama.2020.12603. (Early report drawing attention to persistent fatigue post-COVID in adults.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon AJ, Messer ZR, Medow MS, Stewart JM. Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome. Clin Sci. 2011;122(5):227&#x2013;238. doi: 10.1042/cs20110241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs20110241</ArticleId><ArticleId IdType="pmc">PMC3368269</ArticleId><ArticleId IdType="pubmed">21919887</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pozzi AT, Schwartz CE, Tewari D, Medow MS, Stewart JM. Reduced cerebral lood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome. Hypertension. 2014;63(6):1302&#x2013;1308. doi: 10.1161/HYPERTENSIONAHA.113.02824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.02824</ArticleId><ArticleId IdType="pmc">PMC4016155</ArticleId><ArticleId IdType="pubmed">24711524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CH, Freeman R. Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res. 2005;15(1):40&#x2013;44. doi: 10.1007/s10286-005-0227-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-005-0227-1</ArticleId><ArticleId IdType="pubmed">15768201</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens AP, Low DA, Iodice V, Critchley HD, Mathias CJ. The genesis and presentation of anxiety in disorders of autonomic overexcitation. Autonomic Neuroscience: Basic and Clinical. 2017;203:81&#x2013;87. doi: 10.1016/j.autneu.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2016.10.004</ArticleId><ArticleId IdType="pubmed">27865628</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn D-I, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449&#x2013;451. doi: 10.1007/s10286-020-00727-9.Earlydescriptionofpost-COVIDPOTS.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9.Earlydescriptionofpost-COVIDPOTS</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal AA, et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. 2021;8(11). 10.3390/jcdd8110156. (Review of post-COVID circulatory dysfunction.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger DS. Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child. Neurol Sci. 2021;42(10):3959&#x2013;3963. doi: 10.1007/s10072-021-05345-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05345-5</ArticleId><ArticleId IdType="pmc">PMC8272686</ArticleId><ArticleId IdType="pubmed">34247285</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracek LS, Suskauer SJ, Vickers RF, Patel NR, Violand RL, Swope RL, et al. Adolescent and young adult ME/CFS after confirmed or probable COVID-19. Frontiers in Medicine. 2021;8(525). 10.3389/fmed.2021.668944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116546</ArticleId><ArticleId IdType="pubmed">33996867</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69(2):205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Autonomic Neuroscience. 2021:102828. 10.1016/j.autneu.2021.102828. (Excellent recent review on POTS.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, et al. Postural tachycardia syndrome (POTS) Neurology. 1995;45(4 Suppl 5):S19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">7746369</ArticleId></ArticleIdList></Reference><Reference><Citation>Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43(1):132&#x2013;137. doi: 10.1212/wnl.43.1_part_1.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.43.1_part_1.132</ArticleId><ArticleId IdType="pubmed">8423877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonyhay I, Freeman R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation. 2004;110(20):3193&#x2013;3198. doi: 10.1161/01.Cir.0000147280.90339.E9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.Cir.0000147280.90339.E9</ArticleId><ArticleId IdType="pubmed">15533861</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc. 1999;74(11):1106&#x2013;1110. doi: 10.4065/74.11.1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/74.11.1106</ArticleId><ArticleId IdType="pubmed">10560597</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res. 2020;30(4):299&#x2013;315. doi: 10.1007/s10286-020-00714-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00714-0</ArticleId><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Khoury JA, Blair JE, Grill MF. COVID-19 dysautonomia. Front Neurol. 2021;12:624968. doi: 10.3389/fneur.2021.624968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning WT, 3rd, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies. J Am Heart Assoc. 2019;8(18):e013602. doi: 10.1161/jaha.119.013602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.119.013602</ArticleId><ArticleId IdType="pmc">PMC6818019</ArticleId><ArticleId IdType="pubmed">31495251</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3(1):e000755. doi: 10.1161/jaha.113.000755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.113.000755</ArticleId><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. The National Academies Collection: Reports funded by National Institutes of Health. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US) Copyright 2015 by the National Academy of Sciences. All rights reserved.; 2015. (Comprehensive review of the core symptoms and diagnosis of ME/CFS.)</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun Rev. 2018;17(6):601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bynke A, Julin P, Gottfries CG, Heidecke H, Scheibenbogen C, Bergquist J. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts. Brain Behav Immun Health. 2020;7:100107. doi: 10.1016/j.bbih.2020.100107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100107</ArticleId><ArticleId IdType="pmc">PMC8474431</ArticleId><ArticleId IdType="pubmed">34589868</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-Covid-19 fatigue syndrome analogous to ME/CFS. Front Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012;26(1):24&#x2013;31. doi: 10.1016/j.bbi.2011.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.06.016</ArticleId><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart CC, Cookfair DL, Hovey KM, Wende KE, Bell DS, Warner CL. Predictive immunophenotypes: disease-related profile in chronic fatigue syndrome. Cytometry B Clin Cytom. 2003;53(1):26&#x2013;33. doi: 10.1002/cyto.b.10034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.b.10034</ArticleId><ArticleId IdType="pubmed">12717688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Kuratsune H, Watanabe Y. Neuroinflammation in the brain of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Brain Nerve. 2018;70(1):19&#x2013;25. doi: 10.11477/mf.1416200945.</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200945</ArticleId><ArticleId IdType="pubmed">29348371</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda M, Ifuku M, Hossain MS, Katafuchi T. Glial activation and expression of the serotonin transporter in chronic fatigue syndrome. Front Psychiatry. 2018;9:589. doi: 10.3389/fpsyt.2018.00589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00589</ArticleId><ArticleId IdType="pmc">PMC6250825</ArticleId><ArticleId IdType="pubmed">30505285</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford JA. The neuroinflammatory etiopathology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Physiol. 2017;8:88. doi: 10.3389/fphys.2017.00088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00088</ArticleId><ArticleId IdType="pmc">PMC5314655</ArticleId><ArticleId IdType="pubmed">28261110</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CMC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020;5:50&#x2013;58. doi: 10.1016/j.cnp.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM, Gewitz MH, Weldon A, Arlievsky N, Li K, Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics. 1999;103(1):116&#x2013;121. doi: 10.1542/peds.103.1.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.103.1.116</ArticleId><ArticleId IdType="pubmed">9917448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani M, Fathi Jouzdani A, Motarjem S, Ranjbar A, Khansari N. How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A review of mechanisms and evidence. Neurol Clin Neurosci. 2021;9(6):434&#x2013;442. doi: 10.1111/ncn3.12548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12548</ArticleId><ArticleId IdType="pmc">PMC8661735</ArticleId><ArticleId IdType="pubmed">34909198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020;17(11):1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Han J, Cheng X, Yu L, Zhang L, Wang W, et al. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients. Sci Rep. 2020;10(1):17718. doi: 10.1038/s41598-020-73955-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73955-8</ArticleId><ArticleId IdType="pmc">PMC7573596</ArticleId><ArticleId IdType="pubmed">33077873</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, Frattari GS, Olesen R, Andersen R, et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11(1):10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10(6). 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. 2021;41(8):BSR20210611. doi: 10.1042/bsr20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bsr20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertin D, Kaphan E, Weber S, Babacci B, Arcani R, Faucher B, et al. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome. Int J Infect Dis. 2021;113:23&#x2013;25. doi: 10.1016/j.ijid.2021.09.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.079</ArticleId><ArticleId IdType="pmc">PMC8487460</ArticleId><ArticleId IdType="pubmed">34614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med (Lausanne) 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature. 2021;590(7844):29&#x2013;31. doi: 10.1038/d41586-021-00149-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00149-1</ArticleId><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CMC, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood low in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina. 2022;58(1):28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, et al. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Frontiers in Pediatrics. 2017;5(121). 10.3389/fped.2017.00121. (Practical Open-Access monograph on the diagnosis and management of pediatric ME/CFS.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof SL, Maijer K, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM. Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity. Pediatrics. 2011;127(5):e1169&#x2013;e1175. doi: 10.1542/peds.2010-1147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-1147</ArticleId><ArticleId IdType="pubmed">21502228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakim A, De Wandele I, O&#x2019;Callaghan C, Pocinki A, Rowe P. Chronic fatigue in Ehlers-Danlos syndrome-hypermobile type. Am J Med Genet C Semin Med Genet. 2017;175(1):175&#x2013;180. doi: 10.1002/ajmg.c.31542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31542</ArticleId><ArticleId IdType="pubmed">28186393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res. 1997;31(1):133&#x2013;147. doi: 10.1016/s0022-3956(96)00047-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3956(96)00047-7</ArticleId><ArticleId IdType="pubmed">9201655</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res. 2000;48(2):218&#x2013;226. doi: 10.1203/00006450-200008000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200008000-00016</ArticleId><ArticleId IdType="pubmed">10926298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Marden CL, Jasion SE, Cranston EM, Flaherty MA, Kelly KJ. Cow&#x2019;s milk protein intolerance in adolescents and young adults with chronic fatigue syndrome. Acta Paediatr. 2016;105(9):e412&#x2013;e418. doi: 10.1111/apa.13476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.13476</ArticleId><ArticleId IdType="pubmed">27177188</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibao C, Arzubiaga C, Roberts LJ, Raj S, Black B, Harris P, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45(3):385&#x2013;390. doi: 10.1161/01.HYP.0000158259.68614.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000158259.68614.40</ArticleId><ArticleId IdType="pubmed">15710782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Marden CL, Flaherty MAK, Jasion SE, Cranston EM, Fontaine KR, et al. Two-year follow-up of impaired range of motion in chronic fatigue syndrome. J Pediatrics. 2018;200:249&#x2013;53.e1. doi: 10.1016/j.jpeds.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.05.012</ArticleId><ArticleId IdType="pubmed">29866593</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance H, Maslach A, Stoneman E, Harmes K, Ransom A, Seagly K, et al. Addressing post-COVID symptoms: a guide for primary care physicians. J Am Board Fam Med. 2021;34(6):1229&#x2013;1242. doi: 10.3122/jabfm.2021.06.210254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2021.06.210254</ArticleId><ArticleId IdType="pubmed">34772779</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplin S. Summary of joint guideline on the management of long COVID. Prescriber. 2021;32(8&#x2013;9):33&#x2013;35. doi: 10.1002/psb.1941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/psb.1941</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention: evaluating and caring for patients with post-COVID conditions: interim guidance. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html (2021). Accessed December 22, 2021 2021.</Citation></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J, Azola A, Baratta JM, Fleming TK, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PMR. 2021;13(9):1027&#x2013;1043. doi: 10.1002/pmrj.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Roma M, Marden CL, Rowe PC. Passive standing tests for the office diagnosis of postural tachycardia syndrome: new methodological considerations. Fatigue: Biomedicine, Health &amp; Behavior. 2018;6(4):179&#x2013;92. 10.1080/21641846.2018.1512836.</Citation></Reference><Reference><Citation>Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136(5):e25&#x2013;e59. doi: 10.1161/cir.0000000000000498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000000498</ArticleId><ArticleId IdType="pubmed">28280232</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CMC, Rowe PC, Visser FC. Compression stockings improve cardiac output and cerebral blood flow during tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients: a randomized crossover trial. Medicina. 2022;58(1):51. doi: 10.3390/medicina58010051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010051</ArticleId><ArticleId IdType="pmc">PMC8781100</ArticleId><ArticleId IdType="pubmed">35056360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourne KM, Sheldon RS, Hall J, Lloyd M, Kogut K, Sheikh N, et al. Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2021;77(3):285&#x2013;296. doi: 10.1016/j.jacc.2020.11.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.040</ArticleId><ArticleId IdType="pubmed">33478652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Levine BD. Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018;215:20&#x2013;27. doi: 10.1016/j.autneu.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.07.001</ArticleId><ArticleId IdType="pmc">PMC6289756</ArticleId><ArticleId IdType="pubmed">30001836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41&#x2013;63. doi: 10.1016/j.hrthm.2015.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.03.029</ArticleId><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Walsh-Messinger J, Manis H, Vrabec A, Sizemore BSJ, Bishof K, Debidda M, et al. The kids are not alright: a preliminary report of Post-COVID syndrome in university students. Journal of American College Health. 2021:1&#x2013;7. 10.1080/07448481.2021.1927053. (Early report on the impact of long COVID in university students.)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742843</ArticleId><ArticleId IdType="pubmed">34242539</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):500&#x2013;509. doi: 10.1212/wnl.0000000000008105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000008105</ArticleId><ArticleId IdType="pmc">PMC6746206</ArticleId><ArticleId IdType="pubmed">31413170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;59(4):490&#x2013;498. doi: 10.1212/wnl.59.4.490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.59.4.490</ArticleId><ArticleId IdType="pubmed">12196640</ArticleId></ArticleIdList></Reference><Reference><Citation>Langdon R, DiSabella MT. Pediatric headache: an overview. Curr Probl Pediatr Adolesc Health Care. 2017;47(3):44&#x2013;65. doi: 10.1016/j.cppeds.2017.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cppeds.2017.01.002</ArticleId><ArticleId IdType="pubmed">28366491</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Molderings GJ. A concise, practical guide to diagnostic assessment for mast cell activation disease. World Journal of Hematology. 2014;3(1):1&#x2013;17. doi: 10.5315/wjh.v3.i1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5315/wjh.v3.i1.1</ArticleId><ArticleId IdType="pmc">PMC3069946</ArticleId><ArticleId IdType="pubmed">21418662</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124(1):189&#x2013;193. doi: 10.1542/peds.2008-1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS) J Cardiovasc Electrophysiol. 2009;20(3):352&#x2013;358. doi: 10.1111/j.1540-8167.2008.01407.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01407.x</ArticleId><ArticleId IdType="pmc">PMC3904426</ArticleId><ArticleId IdType="pubmed">19207771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM, Javaid S, Fialkoff T, Tuma-Marcella B, Visintainer P, Terilli C, et al. Initial orthostatic hypotension causes (transient) postural tachycardia. J Am Coll Cardiol. 2019;74(9):1271&#x2013;1273. doi: 10.1016/j.jacc.2019.06.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.06.054</ArticleId><ArticleId IdType="pmc">PMC7024570</ArticleId><ArticleId IdType="pubmed">31466625</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69&#x2013;72. doi: 10.1007/s10286-011-0119-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-011-0119-5</ArticleId><ArticleId IdType="pubmed">21431947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. 1995;274(12):961&#x2013;967. doi: 10.1001/jama.1995.03530120053041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03530120053041</ArticleId><ArticleId IdType="pubmed">7674527</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkisson WO, Benditt DG. Pathophysiology of reflex syncope: a review. J Cardiovasc Electrophysiol. 2017;28(9):1088&#x2013;1097. doi: 10.1111/jce.13266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13266</ArticleId><ArticleId IdType="pubmed">28776824</ArticleId></ArticleIdList></Reference><Reference><Citation>Benditt DG, Adkisson WO. Approach to the patient with syncope: venues, presentations, diagnoses. Cardiol Clin. 2013;31(1):9&#x2013;25. doi: 10.1016/j.ccl.2012.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccl.2012.09.002</ArticleId><ArticleId IdType="pubmed">23217684</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubb BP. Neurocardiogenic syncope. N Engl J Med. 2005;352(10):1004&#x2013;1010. doi: 10.1056/NEJMcp042601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp042601</ArticleId><ArticleId IdType="pubmed">15758011</ArticleId></ArticleIdList></Reference><Reference><Citation>Roma M, Marden CL, De Wandele I, Francomano CA, Rowe PC. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Autonomic Neuroscience: Basic and Clinical. 2018;215:89&#x2013;96. doi: 10.1016/j.autneu.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.006</ArticleId><ArticleId IdType="pubmed">29519641</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Marden CL, Flaherty MAK, Jasion SE, Cranston EM, Johns AS, et al. Impaired range of motion of limbs and spine in chronic fatigue syndrome. J Pediatrics. 2014;165(2):360&#x2013;366. doi: 10.1016/j.jpeds.2014.04.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2014.04.051</ArticleId><ArticleId IdType="pubmed">24929332</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, et al. Diagnosis of mast cell activation syndrome: a global &#x201c;consensus-2&#x201d;. Diagnosis. 2020 doi: 10.1515/dx-2020-0005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0005</ArticleId><ArticleId IdType="pubmed">32324159</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LS, Greene JW. The functional disability inventory: measuring a neglected dimension of child health status. J Pediatr Psychol. 1991;16(1):39&#x2013;58. doi: 10.1093/jpepsy/16.1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpepsy/16.1.39</ArticleId><ArticleId IdType="pubmed">1826329</ArticleId></ArticleIdList></Reference><Reference><Citation>Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800&#x2013;12. 10.1097/00005650-200108000-00006.</Citation><ArticleIdList><ArticleId IdType="pubmed">11468499</ArticleId></ArticleIdList></Reference><Reference><Citation>Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol. 2004;31(12):2494&#x2013;2500.</Citation><ArticleIdList><ArticleId IdType="pubmed">15570657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentall RP, Wood GC, Marrinan T, Deans C, Edwards RH. A brief mental fatigue questionnaire. Br J Clin Psychol. 1993;32(3):375&#x2013;379. doi: 10.1111/j.2044-8260.1993.tb01070.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1993.tb01070.x</ArticleId><ArticleId IdType="pubmed">7902751</ArticleId></ArticleIdList></Reference><Reference><Citation>White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety and Depression Scale for use with adolescents. Br J Psychiatry. 1999;175:452&#x2013;454. doi: 10.1192/bjp.175.5.452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.175.5.452</ArticleId><ArticleId IdType="pubmed">10789277</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Steer RA, Brown GK. Beck depression inventory (BDI-II). Pearson; 1996.</Citation></Reference><Reference><Citation>Winker R, Prager W, Haider A, Salameh B, R&#xfc;diger HW. Schellong test in orthostatic dysregulation: a comparison with tilt-table testing. Wien Klin Wochenschr. 2005;117(1&#x2013;2):36&#x2013;41. doi: 10.1007/s00508-004-0288-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-004-0288-5</ArticleId><ArticleId IdType="pubmed">15986589</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs RD, Brignole M, Falup-Pecurariu C, Fanciulli A, Freeman R, Guaraldi P, et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness. Clin Auton Res. 2021;31(3):369&#x2013;384. doi: 10.1007/s10286-020-00738-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00738-6</ArticleId><ArticleId IdType="pmc">PMC8184725</ArticleId><ArticleId IdType="pubmed">33740206</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>